IGF1 and prostate carcinoma: Therefore, further investigation of co-targeting reciprocal interactions of AR and IGF1 pathways between epithelial tumor cells and surrounding tumor niches may provide insight into potential therapeutic strategies for treating advanced prostate cancer.